Are there studies looking at Ra-223 and SBRT for oligometastatic disease in the setting of mCRPC?
1 Answers
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network
Yes, quite a few including one from UCLA-
Yes, quite a few including one from UCLA-